KABRADGPharmaceuticals
Kabra Drugs Ltd — PE Ratio & Valuation Analysis
₹24.58
-3.19%
Current P/E62.38xPrice to earnings
Industry P/E31.77xSector average
⚠️
96.3% Premium to Industry
KABRADG P/E 62.38x vs sector avg 31.77x
💡
Understanding Kabra Drugs Ltd Valuation
Kabra Drugs Ltd (KABRADG) currently trades at 62.38x earnings. The Pharmaceuticals sector average PE is 31.77x. KABRADG commands a premium, reflecting high growth expectations. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
-8.47%
Dividend Yield
0.00%
More on Kabra Drugs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.